Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H17NOS |
| Molecular Weight | 307.409 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C(=S)OC1=CC=C2C=CC=CC2=C1)C3=CC=CC(C)=C3
InChI
InChIKey=FUSNMLFNXJSCDI-UHFFFAOYSA-N
InChI=1S/C19H17NOS/c1-14-6-5-9-17(12-14)20(2)19(22)21-18-11-10-15-7-3-4-8-16(15)13-18/h3-13H,1-2H3
| Molecular Formula | C19H17NOS |
| Molecular Weight | 307.409 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/monograph/tolnaftate.htmlCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3524433
Sources: https://www.drugs.com/monograph/tolnaftate.html
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3524433
Tolnaftate is a thiocarbamate derivative used as an over-the-counter anti-fungal agent for treatment of athlete's foot and ringworm. Tolnaftate acts by inhibition of ergosterol biosynthesis pathway in fungal cells.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q92206 Gene ID: 3646458|||3646509 Gene Symbol: ERG1 Target Organism: Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3524433 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | TINACTIN Approved UseTreatment of tinea corporis (body ringworm) and tinea cruris (jock itch) caused by Epidermophyton floccosum, Microsporum canis, M. audouinii, Trichophyton mentagrophytes, T. rubrum, or T. tonsurans. |
|||
| Curative | TINACTIN Approved UseTreatment of tinea corporis (body ringworm) and tinea cruris (jock itch) caused by Epidermophyton floccosum, Microsporum canis, M. audouinii, Trichophyton mentagrophytes, T. rubrum, or T. tonsurans. |
|||
| Curative | TINACTIN Approved UseTreatment of tinea pedis (athlete’s foot) and tinea manuum (hand ringworm) caused by E. floccosum, M. canis, M. audouinii, T. mentagrophytes, T. rubrum, or T. tonsurans. |
|||
| Curative | TINACTIN Approved UseTreatment of tinea pedis (athlete’s foot) and tinea manuum (hand ringworm) caused by E. floccosum, M. canis, M. audouinii, T. mentagrophytes, T. rubrum, or T. tonsurans. |
|||
| Curative | TINACTIN Approved UseTreatment of pityriasis (tinea) versicolor caused by Malassezia furfur (Pityrosporum orbiculare or P. ovale). |
PubMed
| Title | Date | PubMed |
|---|---|---|
| FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | 2013-09-05 |
|
| Targeted protein depletion in Saccharomyces cerevisiae by activation of a bidirectional degron. | 2010-12-29 |
|
| Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures. | 2010-10-27 |
|
| Sli15(INCENP) dephosphorylation prevents mitotic checkpoint reengagement due to loss of tension at anaphase onset. | 2010-08-10 |
|
| Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. | 2010-08 |
|
| Assay of tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography. | 2010-07-20 |
|
| Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts. | 2010-06-15 |
|
| One-hit wonders of genomic instability. | 2010-05-19 |
|
| Current concepts in systemic and topical therapy for superficial mycoses. | 2010-03-04 |
|
| Otomycosis: Diagnosis and treatment. | 2010-03-04 |
|
| Both interaction surfaces within cohesin's hinge domain are essential for its stable chromosomal association. | 2010-02-23 |
|
| Proteasome nuclear activity affects chromosome stability by controlling the turnover of Mms22, a protein important for DNA repair. | 2010-02-19 |
|
| In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. | 2010-02-03 |
|
| Fungicide-driven evolution and molecular basis of multidrug resistance in field populations of the grey mould fungus Botrytis cinerea. | 2009-12 |
|
| Trichomycoses. | 2009-07 |
|
| Label-free detection of drug-membrane association using ultraviolet-visible sum-frequency generation. | 2009-02-04 |
|
| Conserved features of cohesin binding along fission yeast chromosomes. | 2009 |
|
| Efficient protein depletion by genetically controlled deprotection of a dormant N-degron. | 2009 |
|
| PTTG: an important target gene for ovarian cancer therapy. | 2008-10-20 |
|
| Heterologous expression of plasmodial proteins for structural studies and functional annotation. | 2008-10-01 |
|
| Are placebo-controlled trials of creams for athlete's foot still justified? | 2008-09 |
|
| Functional characterization of cohesin subunit SCC1 in Trypanosoma brucei and dissection of mutant phenotypes in two life cycle stages. | 2008-08 |
|
| E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughout C. elegans development. | 2008-07-18 |
|
| RIP and RALyase cleave the sarcin/ricin domain, a critical domain for ribosome function, during senescence of wheat coleoptiles. | 2008-06-13 |
|
| Cell-type-specific TEV protease cleavage reveals cohesin functions in Drosophila neurons. | 2008-02 |
|
| Inhibitory phosphorylation of separase is essential for genome stability and viability of murine embryonic germ cells. | 2008-01 |
|
| Displacement and re-accumulation of centromeric cohesin during transient pre-anaphase centromere splitting. | 2007-12 |
|
| Topical treatments for fungal infections of the skin and nails of the foot. | 2007-07-18 |
|
| Polo-like kinase controls vertebrate spindle elongation and cytokinesis. | 2007-05-02 |
|
| Identification of the C. elegans anaphase promoting complex subunit Cdc26 by phenotypic profiling and functional rescue in yeast. | 2007-03-20 |
|
| A multi-step pathway for the establishment of sister chromatid cohesion. | 2007-01-19 |
|
| PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. | 2007 |
|
| ProFAT: a web-based tool for the functional annotation of protein sequences. | 2006-10-23 |
|
| The eggshell is required for meiotic fidelity, polar-body extrusion and polarization of the C. elegans embryo. | 2006-10-16 |
|
| [Use of topical antifungal agents]. | 2006-09-23 |
|
| Study on the supramolecular multirecognition mechanism of beta-naphthol/beta-cyclodextrin/anionic surfactant in a tolnaftate hydrolysis system. | 2006-05-04 |
|
| Highly sensitive and selective spectrofluorimetric determination of tolnaftate through the formation of ternary inclusion complex of beta-naphthol/beta-cyclodextrin/anionic surfactant system. | 2006-03-15 |
|
| Nuclear distribution and chromatin association of DNA polymerase alpha-primase is affected by TEV protease cleavage of Cdc23 (Mcm10) in fission yeast. | 2005-06-07 |
|
| The identification of foam-forming soluble proteins from wheat (Triticum aestivum) dough. | 2005-04 |
|
| Shugoshin prevents dissociation of cohesin from centromeres during mitosis in vertebrate cells. | 2005-03 |
|
| Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. | 2005-03 |
|
| Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates. | 2004-12 |
|
| Validation of a liquid chromatography assay for the quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serum. | 2004-09-25 |
|
| Tolnaftate spray treatment during pregnancy. | 2004-05 |
|
| [Antimycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis]. | 2004 |
|
| Involvement of fatty acid pathways and cortical interaction of the pronuclear complex in Caenorhabditis elegans embryonic polarity. | 2003-10-03 |
|
| A study of dermatophytes and their in-vitro antifungal sensitivity. | 2002-04 |
|
| Ergosterol biosynthesis inhibition: a target for antifungal agents. | 1995 |
|
| [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent]. | 1991-02 |
|
| Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. | 1986-05 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/monograph/tolnaftate.html
Apply topically to the infected skin as a 1% cream, aerosol liquid spray, aerosol powder spray, powder, or solution.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3524433
Ergosterol biosynthesis in fungal cells from Candida albicans, Candida parapsilosis and Trichophyton mentagrophytes was measured by incubation of cells were incubated with [U-14C]acetate at pH 6.5 for 2 hrs and quantification of nonsaponifiable lipids by thin layer chromatography. Tolnaftate inhibited ergosterol biosynthesis with IC50 of about 0.1-1.0 mg/l.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:36:50 GMT 2025
by
admin
on
Mon Mar 31 17:36:50 GMT 2025
|
| Record UNII |
06KB629TKV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QD01AE18
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
||
|
CFR |
21 CFR 524.2350
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
||
|
EPA PESTICIDE CODE |
122901
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
||
|
WHO-ATC |
D01AE18
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
||
|
CFR |
21 CFR 333.210
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9620
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
5510
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
10637
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | RxNorm | ||
|
3617
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
SUB11163MIG
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
DTXSID3042477
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
100000077758
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
C47763
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL83668
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
1730
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
219-266-6
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
TOLNAFTATE
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
06KB629TKV
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
233648
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
1671006
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
Tolnaftate
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
D014047
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
m10948
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
2398-96-1
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
DB00525
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY | |||
|
06KB629TKV
Created by
admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |